Compounds > 3-(2,2,2-trimethylhydrazine)propionate
Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and Cardiomyopathy, Dilated

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Cardiomyopathy, Dilated in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golokolenova, GM; Ol'binskaia, LI1

Trials

1 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Cardiomyopathy, Dilated

ArticleYear
[Use of mindronate in cardiac insufficiency in patients with ischemic heart disease].
    Klinicheskaia meditsina, 1990, Volume: 68, Issue:1

    Topics: Adult; Aged; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Female; Hemodynamics; Humans; Male; Methylhydrazines; Middle Aged; Vasodilator Agents

1990